http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005272696-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1349da2227ebf395de3bd6ad786f479 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
| filingDate | 2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b1b7245d2932b3b9c4372f12eed1a4 |
| publicationDate | 2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005272696-A1 |
| titleOfInvention | Methods of selectively treating diseases with specific glycosaminoglycan polymers |
| abstract | The present invention demonstrates that defined, specific GAG molecules have discerned differential effects, and that different types of cancers are prevented from proliferating and/or killed by oligosaccharides of different sizes; one size sugar does not treat all cancers effectively. Likewise, certain size GAGs have more potent angiogenic properties; thus, mixtures of different sizes of GAG molecules are not optimal. Therefore, the present invention is directed to methods of “personalized medicine”, in which customized defined, specific GAG molecules are administered to a patient, wherein the defined, specific GAG molecules are chosen based on the specific ailment from which the patient is suffering and/or the response of in vitro testing of the ability of the defined, specific GAG molecules to treat, inhibit and/or prevent the ailment in a sample from the patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009215710-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9603945-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687559-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925209-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008226690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9629914-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580290-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010036001-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010290989-A1 |
| priorityDate | 1998-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 570.